In vivo and in vitro degradation of peptide YY3–36 to inactive peptide YY3–34 in humans

Effects of PYY3–36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men

(2014) Julie Berg Schmidt et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

PYY3-36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in mice

(2013) Yan-Chuan Shi et al.   Obesity

Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice

(2012) Hannelouise Kissow et al.   REGULATORY PEPTIDES

A Role for Metalloendopeptidases in the Breakdown of the Gut Hormone, PYY3–36

(2011) Melisande L. Addison et al.   ENDOCRINOLOGY

Kinetic Study of Neuropeptide Y (NPY) Proteolysis in Blood and Identification of NPY3–35

(2009) Karim Abid et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man

(2009) A.-B. Witte et al.   REGULATORY PEPTIDES

Molecular recognition of the NPY hormone family by their receptors

(2008) Diana Lindner et al.   NUTRITION

Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake

(2008) Carel W le Roux et al.   ANNALS OF CLINICAL BIOCHEMISTRY